The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,098.00
Bid: 9,110.00
Ask: 9,114.00
Change: 120.00 (1.34%)
Spread: 4.00 (0.044%)
Open: 9,066.00
High: 9,144.00
Low: 9,008.00
Prev. Close: 8,978.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NXG/CME

7 Aug 2018 15:30

RNS Number : 0839X
Syquant Capital
07 August 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NEX Group PLC

 

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

6th August 2018

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES - CME Group Inc.

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

17.5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Derivatives (other than options):

4,470,651

1.18

 

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

4,470,651

1.18

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

17.5p ordinary

17.5p ordinary

17.5p ordinary

CFD

CFD

CFD

Increasing a long position

Increasing a long position

Increasing a long position

100,000

26,972

15,000

1012 GBp

1011 GBp

1010.75 GBp

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

7th August 2018

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETSSAFFWFASEFA
Date   Source Headline
8th Jul 20219:15 amRNSHolding(s) in Company
5th Jul 202112:45 pmRNSDirector Declaration
1st Jul 202111:27 amRNSTotal Voting Rights
1st Jun 20219:26 amRNSTotal Voting Rights
20th May 20211:48 pmRNSDisclosure of Rights Attaching to Equity Shares
20th May 20211:47 pmRNSSection 430 (2B) Companies Act 2006 Statement
20th May 20211:47 pmRNSResult of AGM
17th May 20215:01 pmRNSHolding(s) in Company
6th May 20215:13 pmRNSDirector/PDMR Shareholding
6th May 20217:00 amRNSTrading Statement
4th May 20215:28 pmRNSTotal Voting Rights
20th Apr 202111:24 amRNSAnnual Financial Report
7th Apr 20214:38 pmRNSDirector/PDMR Shareholding
7th Apr 20214:37 pmRNSDirector/PDMR Shareholding
6th Apr 20214:31 pmRNSDirector/PDMR Shareholding
1st Apr 202110:47 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSNEXT PLC-Results for the Year Ending January 2021
24th Mar 20216:10 pmRNSHolding(s) in Company
10th Mar 202111:00 amRNSNEXT PLC - Acquisition of an Interest in Reiss
1st Mar 20219:00 amRNSTotal Voting Rights
1st Feb 20219:37 amRNSTotal Voting Rights
25th Jan 202112:59 pmRNSBlock listing Interim Review
20th Jan 202110:11 amRNSDirector/PDMR Shareholding
19th Jan 20218:51 amRNSChange in External Directorships
11th Jan 20213:53 pmRNSHolding(s) in Company
5th Jan 20214:55 pmRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSNEXT PLC - Trading Statement
4th Jan 20219:25 amRNSTotal Voting Rights
8th Dec 20201:20 pmRNSHolding(s) in Company
1st Dec 20201:53 pmRNSTotal Voting Rights
17th Nov 20205:39 pmRNSDirector/PDMR Shareholding
16th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20205:52 pmRNSDirector/PDMR Shareholding
2nd Nov 202011:00 amRNSTotal Voting Rights
28th Oct 20202:59 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSTrading Statement
19th Oct 20204:00 pmRNSHolding(s) in Company
1st Oct 20209:26 amRNSTotal Voting Rights
25th Sep 20205:20 pmRNSReplacement:Results for Half Year Ending July 2020
21st Sep 20205:20 pmRNSDirector/PDMR Shareholding
21st Sep 20205:14 pmRNSDirector/PDMR Shareholding
18th Sep 20203:02 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSResults for the Half Year Ending July 2020
1st Sep 20201:38 pmRNSTotal Voting Rights
3rd Aug 20202:41 pmRNSTotal Voting Rights
29th Jul 20207:00 amRNSTrading Statement
24th Jul 20202:25 pmRNSBlock listing Interim Review
13th Jul 20201:07 pmRNSDirectorate Change
3rd Jul 20204:37 pmRNSHolding(s) in Company
1st Jul 20203:25 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.